EU won't take up option to buy more Astrazeneca vaccines
The EU has opted out of buying more vaccine doses from Astrazeneca and instead plans to buy vaccines from Pfizer/Biontech, since the latter company has better met the demands of its contract, and since its vaccine type has less severe side effects than those possibly connected with the Astrazeneca vaccine.
BY LOUISE WENDT JENSEN, TRANSLATED BY NIELSINE NIELSEN
BRUXELLES
Already a subscriber?Log in here
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
